We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+18.69%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$831M
AUM Growth
+$95.7M
Cap. Flow
-$18.2M
Cap. Flow %
-2.19%
Top 10 Hldgs %
37.16%
Holding
117
New
13
Increased
23
Reduced
36
Closed
11

Top Buys

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$28.2M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$16.5M
3
MRK icon
Merck
MRK
+$12.9M
4
AGN
Allergan plc
AGN
+$12.3M
5
ASMB icon
Assembly Biosciences
ASMB
+$11.8M

Top Sells

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$26.1M
2
FOLD
Amicus Therapeutics
FOLD
+$20.1M
3
CELG
Celgene Corp
CELG
+$19M
4
IMMU
Immunomedics Inc
IMMU
+$18.6M
5
AERI
Aerie Pharmaceuticals
AERI
+$12.9M

Sector Composition

Rank Sector Weight
1 Healthcare 84.63%
2 Industrials 2.17%
3 Technology 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DERM
76
DELISTED
Dermira, Inc.
DERM
$568K 0.07%
41,902
– –
KALV
77
DELISTED
KalVista Pharmaceuticals
KALV
$502K 0.06%
17,551
– –
HUM icon
78
Humana
HUM
$44B
$490K 0.06%
1,841
+5
+0.3% +$1.44K
ONCE
79
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$405K 0.05%
+3,554
New +$261K
UHS icon
80
Universal Health Services
UHS
$9.88B
$385K 0.05%
2,881
-15
-0.5% -$1.98K
ZLAB icon
81
Zai Lab
ZLAB
$2.06B
$372K 0.04%
12,589
– –
BPMC
82
DELISTED
Blueprint Medicines
BPMC
$335K 0.04%
4,184
– –
TLPH icon
83
Talphera
TLPH
$70.1M
$257K 0.03%
3,689
– –
CCXI
84
DELISTED
ChemoCentryx, Inc.
CCXI
$247K 0.03%
17,811
– –
SRRA
85
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$240K 0.03%
3,509
-1,533
-30% -$98.4K
CNC icon
86
Centene
CNC
$30.1B
$222K 0.03%
4,180
+20
+0.5% +$1.21K
MYOK
87
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$211K 0.03%
+4,051
New +$187K
BHVN
88
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$201K 0.02%
+3,900
New +$168K
KURA icon
89
Kura Oncology
KURA
$826M
$196K 0.02%
11,800
– –
RVNC
90
DELISTED
Revance Therapeutics, Inc.
RVNC
$177K 0.02%
11,234
– –
QTNT
91
DELISTED
Quotient Limited Ordinary Shares
QTNT
$159K 0.02%
441
– –
IMGN
92
DELISTED
Immunogen Inc
IMGN
$157K 0.02%
58,013
-77,300
-57% -$335K
PTGX icon
93
Protagonist Therapeutics
PTGX
$8.92B
$143K 0.02%
11,400
– –
ATRS
94
DELISTED
Antares Pharma, Inc.
ATRS
$143K 0.02%
47,280
– –
LITS
95
Lite Strategy Inc
LITS
$33.6M
$137K 0.02%
2,227
– –
CYTK icon
96
Cytokinetics
CYTK
$10.9B
$126K 0.02%
15,582
– –
CTMX icon
97
CytomX Therapeutics
CTMX
$714M
$108K 0.01%
10,058
– –
SYRE icon
98
Spyre Therapeutics
SYRE
$8.81B
$104K 0.01%
518
– –
ABEO icon
99
Abeona Therapeutics
ABEO
$369M
$93K 0.01%
507
– –
NBRV
100
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$93K 0.01%
153
– –
1 2 3
4
5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Sectoral Asset Management held 117 positions worth $831M, up 13% from $736M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sectoral Asset Management's Q1 2019 filing shows 13 new, 23 increased, 36 reduced and 11 closed positions. Its largest new stake was Shockwave Medical, Inc. Common Stock: 849,811 shares worth $28.4M. The largest sale was Array Biopharma Inc, an estimated $26.1M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 82% a quarter earlier, followed by Industrials and Technology.

  • Sectoral Asset Management's largest Q1 2019 buy was Shockwave Medical, Inc. Common Stock: 849,811 shares worth $28.4M.
  • Sectoral Asset Management added most to Assembly Biosciences in Q1 2019, an estimated $11.8M increase.
  • Sectoral Asset Management's biggest Q1 2019 reduction was Array Biopharma Inc, cutting an estimated $26.1M.
  • Sectoral Asset Management fully exited Immunomedics Inc in Q1 2019, selling an estimated $18.6M.
  • Sectoral Asset Management's ten largest holdings make up 37% of its $831M portfolio in Q1 2019.
  • Sectoral Asset Management opened 13 new positions and closed 11 in Q1 2019.
  • Sectoral Asset Management's portfolio value rose 13% quarter-over-quarter to $831M.

Based on Sectoral Asset Management's 13F filing for Q1 2019, filed 14 May 2019.